The healthcare landscape is undergoing a digital revolution, driven by the increasing adoption of AI in diagnostics and patient management. This presents a groundbreaking opportunity in the Software as a Medical Device (SaMD) market, particularly for applications targeting kidney stone treatment, thus we developed Progalit SaMD with the purpose of automation of treatment and prevention of kidney stone disease. The critical value of Progalit SaMD in the treatment of kidney stone disease is as follows: analysis of patient data, guiding treatment decisions, guiding dietary or medication changes, and monitoring patient progress. Another application of Progalit is evaluation in patients with established kidney stone disease is the prevention of the reoccurrence of stones identifying the particular behavioral and physiologic differences present in a given patient so that effective preventive therapy can be established.